Vimarsana
Biggest News Aggregation in the World

Page 3 - Biotech Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biotech Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biotech Summit Today - Breaking & Trending Today

The National Medtech & Biotech Summit - Vimarsana News

The National Medtech & Biotech Summit

Eventbrite - Premier Publishing & Events presents The National Medtech & Biotech Summit - Tuesday, 23 November 2021 | Wednesday, 24 November 2021 - Find event and ticket information.

BioscienceLA Announces First-Ever LABioTechWeek With Series - Vimarsana News

BioscienceLA Announces First-Ever LABioTechWeek With Series

The life sciences innovation catalyst will celebrate the grand opening of its Culver City collaboration hub with a week of events in partnership with other...

Modern CEOs "didn't sleep" because the U.S. refused patents - Vimarsana News

Modern CEOs "didn't sleep" because the U.S. refused patents

Modern CEOs “didn’t sleep” because the U.S. refused patents Modern CEOs said he “didn’t sleep for a minute” after the U.S. government decided to suspend the patent for the Covid-19 vaccine because of a move that has stunned the pharmaceutical industry. The Biden administration said on Wednesday it would accept it temporary repeal of patents, steps taken by many in the industry against the cancellation of intellectual property rights said the owner dangerous background and was at risk of halting innovation in the sector. Stéphane Bancel, CEO of Moderna, said he believes “it does...

Angela Merkel has condemned the US's refusal of patents on vaccines - Vimarsana News

Angela Merkel has condemned the US's refusal of patents on vaccines

Angela Merkel has come out against the proposal made by the Biden administration suspension of intellectual property rights For Covid-19 vaccines, he said it would have “serious consequences” for vaccine production worldwide. The German chancellor said the limiting factors in the supply of vaccines are “production capabilities and high quality standards, not patents”. “The protection of intellectual property is a source of innovation and should continue to be so in the future,” he added. Merkel was responding to President Joe Biden’s chief trade adviser Katherine Tai and said t...

Valo Health to Participate in Financial Times US Pharma and Biotech Summit - Vimarsana News

Valo Health to Participate in Financial Times US Pharma and Biotech Summit

Valo Health to Participate in Financial Times US Pharma and Biotech Summit News provided by Share this article BOSTON, April 29, 2021 /PRNewswire/ --  Valo Health, LLC (Valo), the technology company that is using human-centric data, machine learning computation and life science expertise to transform and accelerate the drug discovery and development process, today announced that David Berry, Ph.D., founder and Chief Executive Officer of Valo will participate in a panel discussion during the Financial Times US Pharma and Biotech Summit on Wednesday, May 5, 2021 at 11:30 AM ET. The panel, " N...